Stanford Medicine Catalyst

The Stanford Medicine Catalyst application window is now closed

The Stanford Medicine Catalyst is no longer currently accepting applications for it’s next cohort. If you have any questions regarding the process or how our program works, please feel free to email us at sm-catalyst@stanford.edu.

Catalyst is seeking health care innovations from all members of the Stanford community (faculty, university and health care staff, and students) that can significantly impact global health care. Catalyst will award select projects with validated science that hold the promise of becoming world-changing solutions and are ready to be implemented through piloting, advanced prototype development, or early stage utilization. 

*The current Catalyst application window is closed.

 

 

While we are interested in hearing from innovators at any stage of the project life cycle, consider the following in determining whether your idea may be a good fit for Catalyst, now or in the future:

  • This is your best idea. You have a passion for seeing this change the world. Your highest priority is to advance and scale this innovation as fast as possible.
  • You can take personal responsibility for reaching project milestones, can commit to daily involvement in the project, and are able to hold weekly project check-ins with the Catalyst team.
  • Your innovation is unique and has the potential to transform health care.
  • There is a clear market or health care need for your innovation.
  • The basic science underpinnings of your innovation have been validated, and you have some enablement via an early prototype, algorithm, bench validation, etc.
  • With funding (up to $1 million) and Catalyst support, your project can meet its foundational milestones within 9-12 months.
  • Your team has broad diversity in experience and background.
  • You have not created an incorporated entity for the purpose of profiting from the output of the research efforts underlying the innovation’s progression, and/or which may be deemed a conflict of interest under Stanford’s Conflict of Interest Policy.